Pfizer Inc. (PFE.DE)
25.57
-0.30 (-1.18%)
At close: Jan 15, 2025, 4:57 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 144.90B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.73 |
| PE Ratio (ttm) | 35.03 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 54,127 |
| Avg. Volume (20D) | 53,691 |
| Open | 25.75 |
| Previous Close | 25.88 |
| Day's Range | 25.48 - 25.81 |
| 52-Week Range | 23.25 - 29.50 |
| Beta | undefined |
About PFE.DE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable an...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Dec 28, 2007
Employees 88,000
Stock Exchange XETRA
Ticker Symbol PFE.DE
Website https://www.pfizer.com